Abstract
Breast cancer has been considered a public health problem because it is the second most common type of tumor in women. According to the World Health Organization (WHO), currently more than 14 million people develop breast cancer each year, and this number is expected to increase to more than 21 million by 2030. In the last decade, radiolabeled peptides are being used both in therapy and i…